Case Series: Effectiveness and Safety of Telitacicept in Chinese Patients With Primary Sjogren's Disease

被引：0
作者：
Wu, Jiajia [1 ]
Song, You [1 ]
Wang, Weiwei [1 ]
Yuan, Xujing [1 ]
Du, Rong [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Rheumatol & Immunol, Wuhan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2025年 / 28卷 / 03期
关键词：
a proliferation-inducing ligand; B-cell activating factor; EULAR Sjogren's syndrome disease activity index; Sjogren's disease; telitacicept; BELIMUMAB; APRIL; BAFF;
D O I：
10.1111/1756-185X.70174
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：6
相关论文
共 19 条
  • [1] Past and present discovery of the BAFF/APRIL system - A bibliometric study from 1999 to 2023
    Balasubramaniam, Muggunna
    Mokhtar, Ana Masara Ahmad
    [J]. CELLULAR SIGNALLING, 2024, 120
  • [2] Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjogren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
    Bowman, Simon J.
    Fox, Robert
    Doerner, Thomas
    Mariette, Xavier
    Papas, Athena
    Grader-Beck, Thomas
    Fisher, Benjamin A.
    Barcelos, Filipe
    De Vita, Salvatore
    Schulze-Koops, Hendrik
    Moots, Robert J.
    Junge, Guido
    Woznicki, Janice N.
    Sopala, Monika A.
    Luo, Wen-Lin
    Hueber, Wolfgang
    [J]. LANCET, 2022, 399 (10320) : 161 - 171
  • [3] The Involvement of Innate and Adaptive Immunity in the Initiation and Perpetuation of Sjogren's Syndrome
    Chivasso, Clara
    Sarrand, Julie
    Perret, Jason
    Delporte, Christine
    Soyfoo, Muhammad Shahnawaz
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 21
  • [4] Telitacicept: First Approval
    Dhillon, Sohita
    [J]. DRUGS, 2021, 81 (14) : 1671 - 1675
  • [5] Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
    Furie, Richard
    Rovin, Brad H.
    Houssiau, Frederic
    Malvar, Ana
    Teng, Y. K. Onno
    Contreras, Gabriel
    Amoura, Zahir
    Yu, Xueqing
    Mok, Chi-Chiu
    Santiago, Mittermayer B.
    Saxena, Amit
    Green, Yulia
    Ji, Beulah
    Kleoudis, Christi
    Burriss, Susan W.
    Barnett, Carly
    Roth, David A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (12) : 1117 - 1128
  • [6] Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome
    Jonsson, MV
    Szodoray, P
    Jellestad, S
    Jonsson, R
    Skarstein, K
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2005, 25 (03) : 189 - 201
  • [7] A randomized, phase II study of sequential belimumab and rituximab in primary Sjogren's syndrome
    Mariette, Xavier
    Barone, Francesca
    Baldini, Chiara
    Bootsma, Hendrika
    Clark, Kenneth L.
    De Vita, Salvatore
    Gardner, David H.
    Henderson, Robert B.
    Herdman, Michael
    Lerang, Karoline
    Mistry, Prafull
    Punwaney, Raj
    Seror, Raphaele
    Stone, John
    Daele, Paul La van
    van Maurik, Andre
    Wisniacki, Nicolas
    Roth, David A.
    Tak, Paul Peter
    [J]. JCI INSIGHT, 2022, 7 (23)
  • [8] Primary Sjogren's Syndrome
    Mariette, Xavier
    Criswell, Lindsey A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (10) : 931 - 939
  • [9] Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study
    Mariette, Xavier
    Seror, Raphaele
    Quartuccio, Luca
    Baron, Gabriel
    Salvin, Sara
    Fabris, Martina
    Desmoulins, Frederic
    Nocturne, Gaetane
    Ravaud, Philippe
    De Vita, Salvatore
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) : 526 - 531
  • [10] B cells in the pathogenesis of primary Sjogren syndrome
    Nocturne, Gaetane
    Mariette, Xavier
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (03) : 133 - 145
12